- Home
- TORO vs PLX Comparison
TORO vs PLX Comparison
Compare TORO & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TORO | PLX |
|---|---|---|
| Founded | 2022 | 1993 |
| Country | Cyprus | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.5M | 191.0M |
| IPO Year | 2022 | 1996 |
Fundamental Metrics
Financial Performance| Metric | TORO | PLX |
|---|---|---|
| Price | $5.07 | $2.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 27.2K | ★ 604.8K |
| Earning Date | 04-15-2026 | 05-12-2026 |
| Dividend Yield | ★ 36.86% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $52,744,000.00 |
| Revenue This Year | N/A | $36.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.77 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.64 | $1.41 |
| 52 Week High | $8.50 | $3.19 |
Technical Indicators
Market Signals| Indicator | TORO | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 56.96 | 57.52 |
| Support Level | $4.87 | $2.06 |
| Resistance Level | $5.25 | $2.44 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 84.40 | 54.35 |
Price Performance
Historical ComparisonAbout TORO Toro Corp.
Toro Corp is engaged in the acquisition, ownership, chartering, and operation of oceangoing tanker and LPG carrier vessels, providing seaborne transportation services for crude oil, refined petroleum products, and liquefied petroleum gas. The company operates through three segments: the Eco tanker segment, the Non-Eco tanker segment, and the LPG carrier segment. It generates the majority of its revenue from the LPG carrier segment.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.